UBS Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Buy |
|
|||||
|
2025
Q1 | $272K | Sell |
|
|||||
|
2024
Q4 | $1.23M | Buy |
|
|||||
|
2024
Q3 | $130K | Buy |
|
|||||
|
2024
Q2 | $93.2K | Buy |
|
|||||
|
2024
Q1 | $15.8K | Sell |
|
|||||
|
2023
Q4 | $4.96K | Buy |
|
|||||
|
2023
Q3 | $88 | Sell |
|
|||||
|
2023
Q2 | $5.61K | Sell |
|
|||||
|
2023
Q1 | $25.9K | Buy |
|
|||||
|
2022
Q4 | $7.96K | Sell |
|
|||||
|
2022
Q3 | $13K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $17K | Sell |
|
|||||
|
2021
Q4 | $72K | Buy |
|
|||||
|
2021
Q3 | $22K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $11K | Sell |
|
|||||
|
2020
Q3 | $53K | Sell |
|
|||||
|
2020
Q2 | $23K | Sell |
|
|||||
|
2020
Q1 | $9K | Buy |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2019
Q2 | $12K | Buy |
|
|||||
|
2019
Q1 | $3K | Sell |
|
|||||
|
2018
Q4 | $21K | Buy |
|
|||||
|
2018
Q3 | $15K | Buy |
|
|||||
|
2018
Q2 | $11K | Buy |
|
|||||
|
2018
Q1 | $8K | Buy |
|
|||||
|
2017
Q4 | $4K | Sell |
|
|||||
|
2017
Q3 | $24K | Buy |
|
|||||
|
2017
Q2 | $14K | Sell |
|
|||||
|
2017
Q1 | $16K | Sell |
|
|||||
|
2016
Q4 | $71K | Buy |
|
|||||
|
2016
Q3 | $46K | Sell |
|
|||||
|
2016
Q2 | $53K | Buy |
|
|||||
|
2016
Q1 | $39K | Buy |
|
|||||
|
2015
Q4 | $41K | Buy |
|
|||||
|
2015
Q3 | $31K | Buy |
|
|||||
|
2015
Q2 | $52K | Sell |
|
|||||
|
2015
Q1 | $266K | Buy |
|
|||||
|
2014
Q4 | $71K | Buy |
|